MPO and chronic obstructive pulmonary disease: Notably, we now show that the blood concentration of OSM increases during exacerbations in patients with COPD and that this increase is associated with lower blood oxygen levels and higher blood levels of CRP, neutrophils, and myeloperoxidase—an enzyme implicated in both COPD progression and CVD risk [38,39].